Demonstrating the defect of Fas–FasL mediated apoptosis in the lymphocyte apoptotic assay is critical for the diagnosis and study of ALPS, which may also be affected by the use of accutase in the assay. The gene discussed is FASLG; the disease is autoimmune lymphoproliferative syndrome.